Showing results (231-240 of 290) with videos related to
Sort By:
Pageof 29
NPJ Precision Oncology|March 20, 2021
Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) studyApostolia Maria Tsimberidou, David S Hong, Siqing Fu, et al.European Urology|July 8, 2015
Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic ProfilingSumanta K Pal, Toni K Choueiri, Kai Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 27, 2005
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinibDavid A Eberhard, Bruce E Johnson, Lukas C Amler, et al.Plos One|November 28, 2018
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLCMichael E Goldberg, Meagan Montesion, Lauren Young, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2020
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast CancerPingping Mao, Ofir Cohen, Kailey J Kowalski, et al.Journal of Gastrointestinal Oncology|October 12, 2019
Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsyGerald Li, Dean Pavlick, Jon H Chung, et al.Nature Communications|January 22, 2014
Kinase fusions are frequent in Spitz tumours and spitzoid melanomasThomas Wiesner, Jie He, Roman Yelensky, et al.Journal of Hematology & Oncology|November 8, 2018
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumorsCathy Zhou, Zilong Yuan, Weijie Ma, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2016
Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic AlterationsKai Wang, Jeffery S Russell, Jessica D McDermott, et al.Oncology|May 22, 2016
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid CarcinomaAndreas M Heilmann, Vivek Subbiah, Kai Wang, et al.Pageof 29